5,018 ott 2023Quality control analystDipendente attualeConsigliaGradimento del CEOPronostico commercialeVantaggiGood team and good managers, very flexibleSvantaggiOld systems, no bonus, no career opportunitiesMostra di più
1,06 ott 2014Dipendente anonimoEx dipendenteConsigliaGradimento del CEOPronostico commercialeVantaggiThe company closed its US Operation.SvantaggiLack of understanding of FDA by parent company in Australia.Mostra di piùUtileCondividi
5,030 set 2021Research scientistDipendente attuale, più di un annoSydneyConsigliaGradimento del CEOPronostico commercialeVantaggiCompany is the perfect size to be nimble and explorative. Staff are experienced throughout the drug development process. Senior management is well rounded, fair and knowledgeableSvantaggiDon't have any serious issuesMostra di piùUtileCondividi